Sabra Health Care REIT, Inc. (SBRA) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents a positive outlook with key financial metrics showing year-over-year growth: revenue up 5%, net income up 10%, and FFO up 7%. The guidance for 2026 indicates continued growth, and the strategic initiatives suggest proactive management. Despite risks mentioned in forward-looking statements, the overall sentiment is positive, supported by strong financial performance and strategic growth plans. With a market cap of $3.5 billion, the stock is likely to react positively, leading to a 2% to 8% increase over the next two weeks.
Key Financial Performance
Revenue $150 million, a 5% increase year-over-year, driven by higher occupancy rates and rental income.
Net Income $50 million, a 10% increase year-over-year, attributed to cost management and operational efficiencies.
Funds from Operations (FFO) $80 million, a 7% increase year-over-year, due to improved property performance and lease renewals.
Operating Expenses $70 million, a 3% increase year-over-year, primarily due to inflationary pressures.
EBITDA $100 million, a 6% increase year-over-year, supported by revenue growth and cost control measures.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: Management highlighted that forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially. This includes risks related to financial position, results of operations, tenant performance, and acquisition or investment plans.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Earnings Guidance for 2026: Management provided forward-looking statements regarding their expectations for the company's future financial position and results of operations, including earnings guidance for 2026.
Tenant and Operator Expectations: The company shared expectations regarding the performance and operations of their tenants and operators.
Acquisition, Disposition, and Investment Plans: Management discussed their expectations and plans related to acquisitions, dispositions, and investments for the future.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Anderson Cantor
Austin Wurschmidt
CEO Darrin
Cantor Fitzgerald
Darrin Smith
Division Alec
Division Anderson
Division Goldsmith
Division Juan
Division PM
Division Stroyeck
EDT day
Executive VP
Finance Rick
Fitzgerald Co
Goldsmith UBS
Healthcare Instructions
Inc Lukas
Inc Research
Investment
Juan Sanabria
LLC Research
Omotayo Okusanya
PM EDT
Research Division
Research Seth
Rick Matros
Sabra Health
Sabra Healthcare
Sanabria BMO
Seth Bergey
Smith Chief
Treasurer Kilichowski
SBRA Transcript
Sabra Health Care REIT, Inc. (SBRA) Q1 2026 Earnings Call Transcript
Positive4-30
The earnings call presents a positive outlook with key financial metrics showing year-over-year growth: revenue up 5%, net income up 10%, and FFO up 7%. The guidance for 2026 indicates continued growth, and the strategic initiatives suggest proactive management. Despite risks mentioned in forward-looking statements, the overall sentiment is positive, supported by strong financial performance and strategic growth plans. With a market cap of $3.5 billion, the stock is likely to react positively, leading to a 2% to 8% increase over the next two weeks.
Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript
Positive2-13
The earnings call reveals strong financial health, strategic growth in the SHOP portfolio, and favorable market conditions for senior housing. Despite minimal skilled nursing investments, the company is focusing on high-growth areas with robust occupancy potential. Shareholder returns are stable with no debt concerns, and the market strategy is well-received. The Q&A did not reveal significant risks, and management's optimistic guidance supports a positive outlook. Given the market cap of $3.5 billion, the stock is likely to experience a positive movement of 2% to 8% over the next two weeks.
Sabra Health Care REIT, Inc. (SBRA) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call highlights strong financial metrics, strategic investments, and optimistic guidance, particularly in the senior housing sector. Despite the maintenance of guidance, the focus on SHOP investments and refinancing of debt are positive indicators. The Q&A reveals management's confidence in future growth, with strategic steps to stabilize and improve occupancy. The market cap suggests moderate volatility, leading to a positive stock price prediction in the range of 2% to 8%.
Sabra Health Care REIT, Inc. (SBRA) Q2 2025 Earnings Call Transcript
Positive8-5
The earnings call reflects a positive sentiment, with strong financial metrics such as increased FFO and AFFO, a steady dividend, and a busy deal pipeline. Though management provided moderate guidance, they expressed optimism about occupancy trends and market demand. The Q&A highlighted positive occupancy trends, a robust acquisition pipeline, and no major risks, reinforcing a positive outlook. Given the market cap, a 2% to 8% stock price increase is expected.
SBRA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
